Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
With
Pierre Fabre Medicament
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinical diagnosis of transitional cell carcinoma of the urothelium that is locally advanced or metastatic (i.e. patients cannot be candidates for local/regional control of disease).
Relapse or progression within 12.5 months of prior cisplatin or carboplatin containing chemotherapy regimen.
Adequate performance status (Karnofsky greater or equal to 80).
You may not be if
Receipt of more than 1 prior chemotherapy regimen in any setting.
Prior discontinuation of platinum due solely to toxicity.
Current neuropathy greater or equal to CTC grade 2.
Prior radiation to greater or equal to 30% of bone marrow.
